Case Study 83 Leonidas Arvanitis, MD

Slides:



Advertisements
Similar presentations
Case Study 5 Gabrielle Yeaney, M.D.. Question 1 63-year-old female with progressive weakness of upper and lower extremities, in additiona to confusion,
Advertisements

Muscular Dystrophy By: Jamie Wallace.
Inherited Diseases of Muscle: Histologic Features David Lacomis, MD.
Approach to myopathy Dr omid yaghini MUSCLES DISORDERS Definition: Diseases involving the muscle fibers (myogenic) Unlike: neuronopathies: secondary.
Diseases of Muscle: Histopathologic Features
Microscopically Yours: A Glimpse at our Cells, in Sickness and in Health Nina C. Zanetti Siena College Department of Biology.
A 67-year-old male with behavioral and language problems
Case Study 23 Craig Horbinski, M.D., Ph.D.. The patient is a 57 y/o female with a past medical history significant for acute intermittent porphyria. She.
PATHOPHYSIOLOGY PATHOPHYSIOLOGY w DEFINED Involves the study of function that results from disease processes.
David Lacomis, MD Acquired Diseases of Muscle: Histologic Features.
Case Study 7 Craig Horbinski, M.D, Ph.D.. History 63-year-old male with generalized progressive weakness especially in his lower extremities with difficulty.
Case Study 22 Craig Horbinski, M.D., Ph.D.. The patient is a 63 year-old woman from an outside hospital with gradual onset of proximal leg pain, weakness,
Myopathies Pathology Objectives: At the end of this lecture, the students should be able to: Understand the structure of the various types of muscle.
Myopathies Pathology Objectives: At the end of this lecture, the students should be able to: Understand the structure of the various types of muscle.
Katie DePlatchett, M.D. AM Report May 26, 2010 Inflammatory Myopathies.
Case Study 45 Julia Kofler, M.D.. Clinical history: 41 year old male with a 2 year history of progressive hypopituitarism, headache and bitemporal hemianopsia.
Case Study 84 Leonidas Arvanitis, MD
Case Study 42 Henry Armah, M.D., M.Phil.. Question 1 Clinical history: 80-year-old male with past medical history of malignant non-Hodgkin’s lymphoma,
A 53-year-old male with clumsiness Leonidas Arvanitis, M.D. Neuropathology Fellow, PGY-6.
Musculoskeletal block Pathology practical
Case Study 47 Julia Kofler, M.D.. Clinical history: The patient is a 67-year-old female with >6 months history of weakness, mostly in proximal muscles.
Case Study 43 Henry Armah, M.D., M.Phil.. Question 1 Clinical history: 50-year-old female with past medical history of gastroesophageal reflux disease,
Case Study 17 Gabrielle Yeaney, M.D.. 17-year-old female with no past medical history. Describe the MRI findings (location, enhancement, mass effect).
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Reduced Aquaporin 4 Expression in the Muscle Plasma.
Idiopathic Inflammatory Myopathies; how significant is creatine kinase levels in diagnosis and prognosis? Case report and literature review Travis Sizemore.
Case Study 33 Henry Armah, M.D., M.Phil.. Question 1 Clinical history: 53-year-old male who presented with severe back pain and right lower extremity.
Dr. Ashwin Kulkarni M.S.Ramaiah Medicial College Bangalore India
Myopathies Pathology. Myopathies Pathology Objectives: At the end of this lecture, the students should be able to: Understand the structure of the.
Site(s) of Involvement Serum IgG4 Level (mg/dL) Treatment with Steroid
Case Study 21 Craig Horbinski, M.D., Ph.D..
Diseases of Skeletal Muscle
Chapter 15 Lesson 15.3 Striated Smooth Cardiac Muscular dystrophy
Click here for the answer. Click here for the answer.
Click here for the answer. Click here for the answer.
Acute hepatitis of uncertain cause, rule out EBV related
Click here for the answer. Click here for the answer.
History 58 year-old female presented with back pain and right toe numbness. Her past medical history was significant for hypertension, glaucoma and.
Case Study 16 Gabrielle Yeaney, M.D..
Diagnosis and Management of Immune-Mediated Myopathies
Case Study 44 Julia Kofler, M.D..
Chapter 12 Liver Transplantation 1
Diseases of skeletal muscle
Dermatomyositis perifascicular pattern of involvement
Case Study 39 Henry Armah, M.D., M.Phil..
Clayton Wiley M.D./PhD..
Case Study 88 Leonidas Arvanitis, MD
Clevudine myopathy in patients with chronic hepatitis B
NP D.P. Bx: 9/8/2017.
Case Study 41 Henry Armah, M.D., M.Phil..
Case Study 85 Leonidas Arvanitis
Case Study 87 Leonidas Arvanitis, MD
A 57-year-old male who was brought to the ER unresponsive
SIBM: Epidemiology. sIBM: Epidemiology Disease Characteristics: Distinctive Patterns of Muscle Involvement.
Case Study 34 Henry Armah, M.D., M.Phil..
Case Study 86 Leonidas Arvanitis, MD
Case Study 37 Henry Armah, M.D., M.Phil..
Case Study 38 Henry Armah, M.D., M.Phil..
Clayton Wiley, M.D., PhD.
Case Study 40 Henry Armah, M.D., M.Phil..
Figure 1 Muscle biopsy images demonstrating a pauci-immune necrotizing autoimmune myopathy in illustrative cases 1 and 2 (A–D) Case 1 deltoid muscle. Muscle.
Case Study 35 Henry Armah, M.D., M.Phil..
Figure 1 Sections of muscle biopsy specimens stained with hematoxylin & eosin (HE)‏ Sections of muscle biopsy specimens stained with hematoxylin & eosin.
A–c) This lung biopsy from a 55-year-old male patient, who was a nonsmoker, shows a typical desquamative interstitial pneumonia pattern. a–c) This lung.
Case Study 15 Gabrielle Yeaney, M.D..
Pathology Dr.Amany Fathaddin
Case Study 36 Henry Armah, M.D., M.Phil..
Sternohyoid Muscle Biopsy
Figure Clinical, radiologic, and histopathologic findings
Richard J. Sanders, MD 1, William H. Pearce, MD 2 
Dermatomyositis and polymyositis
Presentation transcript:

Case Study 83 Leonidas Arvanitis, MD

Question 1: The patient is a 50-year-old female with AIDS complaining of a 3 month history of muscle weakness Laboratory studies showed a normal EMG and CK levels Describe the findings on an open biopsy of the left quadriceps muscle: Click here to view frozen section H&E slide

Answer 1: Abnormal variation in myofiber sizes (10-100 microns) Clustered and scattered angulated atrophic fibers No excess of internalized nuclei Occasional nuclear clumps No degenerating or regenerating fibers No inflammatory infiltrates

Question 2: What is the most significant histologic finding seen in this biopsy specimen?

Answer 2: Abnormal variation in myofiber sizes (10-100 microns) Clustered and scattered angulated atrophic fibers No excess of internalized nuclei Occasional nuclear clumps No degenerating or regenerating fibers No inflammatory infiltrates

Question 3: How does the pattern of fiber atrophy help us determine the cause for the atrophy?

Answer 3: Changes random and diffuse Myopathy/dystrophy Presence of small angulated fibers Suggests denervation Presence of small group atrophy Denervation Presence of large group atrophy Presence of perifascicular atrophy Dermatomyositis

Question 4: In our case the atrophy is random and diffuse suggestive of a myopathy or dystrophy What histochemical stain would be most helpful in further defining the specific muscle types involved?

Answer 4: ATPase 9.4 ATPase 4.6 Click here to view an ATPase 9.4 stain of a normal muscle biopsy Click here to view an ATPase 4.6 stain of a normal muscle biopsy

Question 5: What is the normal staining pattern of muscle fibers on ATPase 9.4 and 4.6 respectively?

Answer 5: Muscle fiber type 1 2A 2B 2C ATPase 9.4 + +++ ATPase 4.6 - -, +, ++, +++ represent increasing intensity of stain

Question 6: What is the staining pattern of ATPase stains in our case? Click here to view ATPase 9.4 stain Click here to view ATPase 4.6 stain

Answer 6: The atrophic muscle fibers are almost exclusively of the type 2 subtype

Question 7: What additional clinical information would be useful to better define the disease process?

Answer 7: History of alcohol abuse Medication history Other associated comorbidities In our case the patient was treated with corticosteroids

Question 8: What are the causes of type 2 myofiber atrophy?

Answer 8: Alcohol use Steroids Disuse Endocrinopathies Connective tissue disorders

Question 9: Which subtype of type 2 myofibers are particularly affected?

Answer 9: Type 2B fibers

Question 10: What is your final diagnosis?

Answer 10: Type 2 myofiber atrophy due to corticosteroid use